Incidence of thyroid cancer in the Kingdom of Saudi Arabia, 2000-2010

Hematology/ Oncology and Stem Cell Therapy

Volumn 6, Issue 2, 2013, Pages 58-64

  Hussain, Fazal ^a   Iqbal, Samra ^a   Mehmood, Asif ^a   Bazarbashi, Shouki ^b   ElHassan, Tusneem ^a   Chaudhri, Naeem ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b MINISTRY OF HEALTH   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER GRADING; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CHILD; DRUG EFFECT; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PAPILLARY CARCINOMA; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SAUDI ARABIA; SCHOOL CHILD; SEX DIFFERENCE; SEX RATIO; THYROID CANCER; TREND STUDY; UNITED STATES;

EID: 84884703694     PISSN: 16583876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hemonc.2013.05.004     Document Type: Article

References (37)

1. King Faisal Specialist Hospital Tumor Registry Annual Report 2010. Available from http://www.kfshrc.edu.sa/oncology/Tumor%202011%20- New%206%20Final.pdf Accessed August 5, 2012.
2. Cancer Incidence Report, Saudi Arabia 2008. Saudi Cancer Registry. Available from http://scr.org.sa/reports/SCR2008.pdf Accessed August 6, 2012.
3. Ten-Year Cancer Incidence Among Nationals of the GCC States 1998-2007. Gulf Center for Cancer Control and Prevention, Report. Sept 2011, p. 28-31.
4. Cancer Facts and Figures 2012. Thyroid Cancer, p22. American Cancer Society. Available from http://www.cancer.org/acs/groups/content/ @epidemiologysurveilance/documents/document/acspc-031941.pdf Accessed on August 5, 2012.
5. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clinic 2012;62(1):10-29.
6. Al-Nuaim AR, Ahmed M, Bakheet S, et al.. Papillary thyroid cancer in Saudi Arabia. Clinical, pathologic, and management characteristics. Clin Nucl Med 1996;21(4):307-11.
7. Ferlay J, Bray F, Pisani P, Parkin DM. Incidence, mortality and prevalence worldwide, version 1.0. International Agency for Research on Cancer (IARC), WHO. GLOBOCAN 2000: Cancer. IARC CancerBase No. 5. Lyon: IARC Press; 2001. Available from http://globocan.iarc.fr/Accessed September 17, 2012.
8. Global Cancer Facts & Figures 2nd Edition. American Cancer Society. Atlanta, Georgia; 2011. Available from http://www.cancer.org/acs/groups/content/ @epidemiologysurveilance/documents/document/acspc-027766.pdf Accessed August 21, 2012.
9. Grande E, Díez JJ, Zafon C, Capdevila J. Thyroid cancer: molecular aspects and new therapeutic strategies. J Thyroid Res 2012:847108, Epub 2012 Jul 12.
10. Abubaker J, Jehan Z, Bavi P, et al.. Clinicopathological analysis of papillary thyroid cancer with PIK3CA alterations in a Middle Eastern population. J Clin Endocrinol Metab 2008;93(2):611-8.
11. Rahman GA. Extent of surgery for differentiated thyroid cancer: recommended guideline. Oman Med J 2011;26(1):56-8.
12. Kilfoy BA, Zheng T, Holford TR, et al.. International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control 2009;20(5):525-31.
13. Leptin Linked With More Aggressive Thyroid Cancer In Middle Eastern Region. ScienceDaily. American Association for Cancer Research. October 9, 2009. Available from http://www.sciencedaily.com/releases/2009/10/091008192731.htm Accessed August 9, 2012.
14. Thyroid Cancer. Symptoms, risk factors, etiology, treatment - what causes thyroid cancer, and what are risk factors for thyroid cancer? Available from http://emedicine.medscape.com/article/851968- overview Accessed August 7, 2012.
15. Richards BJ. Leptin problems linked to thyroid cancer. Wellness resources. N.p., 25 Jan. 2012 Accessed June 17, 2012.
16. Cheng SP, Yin PH, Hsu YC, et al.. Leptin enhances migration of human papillary thyroid cancer cells through the PI3K/AKT and MEK/ERK signaling pathways. Oncol Rep 2011;26(5):1265-71.
17. Al-Nuaim AR, Al-Mazrou Y, Kamel M, Al-Attas O, Al-Daghari N, Sulimani R. Iodine deficiency in Saudi Arabia. Ann Saudi Med 1997;17(3):293-7.
18. Memon A, Varghese A, Suresh A. Benign thyroid disease and dietary factors in thyroid cancer: a case-control study in Kuwait. Br J Cancer 2002;86(11):1745-50.
19. Ron E, Lubin JH, Shore RE, et al.. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995;141(3):259-77.
20. Thompson DE, Mabuchi K, Ron E, et al.. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Radiat Res 1994;137(2 Suppl.):S17-67.
21. Kerber RA, Till JE, Simon SL, et al.. A cohort study of thyroid disease in relation to fallout from nuclear weapons testing. JAMA 1993;270(17):2076-82.
22. Hamilton TE, van Belle G, LoGerfo JP. Thyroid neoplasia in Marshall Islanders exposed to nuclear fallout. JAMA 1987;258(5):629-35.
23. Cardis E, Kesminiene A, Ivanov V, et al.. Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst 2005;97(10):724-32.
24. Malchoff CD, Malchoff DM. The genetics of hereditary nonmedullary thyroid carcinoma. J Clin Endocrinol Metab 2002;87(6):2455-9.
25. Schulten HJ, Salama S, Al-Mansouri Z, et al.. BRAF mutations in thyroid tumors from an ethnically diverse group. Hered Cancer Clin Pract 2012;10(1):10.
26. Alamoudi O, Hamour OA, Mudawi I, Khayyat A, Batwail N, Elhadd TA. Consensus-based management of differentiated thyroid cancer in tertiary care set-up. Int J Surg 2011;9(1):96-100.
27. Liaw D, Marsh DJ, Li J, et al.. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997;16(1):64-7.
28. Leboulleux S, Baudin E, Travagli JP, Schlumberger M. Medullary thyroid carcinoma. Clin Endocrinol (Oxf) 2004;61(3):299-310.
29. Ravichandran K, Al-Hamdan N, Al-Ageel S. Geographical distribution of thyroid cancer in Saudi Arabia (BESC# 018 2005). King Faisal Specialist Hospital & Research Centre. N.p., n.d. Web. July 8, 2012.
30. Thyroid Cancer Treatment (PDQ®). National Cancer Institute. Available from http://www.cancer.gov/cancertopics/pdq/treatment/thyroid/Health- Professional Accessed July 8, 2012.
31. Uddin S, Hussain AR, Siraj AK, Khan OS, Bavi PP, Al-Kuraya KS. Role of leptin and its receptors in the pathogenesis of thyroid cancer. Int J Clin Exp Pathol 2011;4(7):637-43.
32. Al-Rethaiaa AS, Fahmy AEA, Al-Shwaiyat NM. Obesity and eating habits among college students in Saudi Arabia: a cross sectional study. Nutr J 2010;9:39.
33. Mahfouz AA, Shatoor AS, Khan MY, Daffalla AA, Mostafa OA, Hassanein MA. Nutrition, physical activity, and gender risks for adolescent obesity in southwestern Saudi Arabia. Saudi J Gastroenterol 2011;17(5):318-22.
34. Negri E, Ron E, Franceschi S, et al.. Risk factors for medullary thyroid carcinoma: a pooled analysis. Cancer Causes Control 2002;13(4):365-72.
35. El Mouzan MI, Foster PJ, Al Herbish AS, et al.. Prevalence of overweight and obesity in Saudi children and adolescents. Ann Saudi Med 2010;30(6):203-8.
36. Badran M, Laher I. Obesity in Arabic-speaking countries. J Obes 2011:686430, Epub 2011 Nov 24.
37. Lauren Streib. World's Fattest Countries. Forbes. (Feb 8, 2007). Available from http://www.forbes.com/2007/02/07/worlds-fattest-countries- forbeslife-cx-ls-0208worldfat-2.html Accessed August 25, 2012.